Kellett Wealth Advisors LLC Has $979,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Kellett Wealth Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,860 shares of the healthcare conglomerate’s stock after purchasing an additional 100 shares during the period. UnitedHealth Group comprises approximately 0.7% of Kellett Wealth Advisors LLC’s investment portfolio, making the stock its 25th biggest holding. Kellett Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $979,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Colton Groome Financial Advisors LLC grew its stake in shares of UnitedHealth Group by 9.2% in the fourth quarter. Colton Groome Financial Advisors LLC now owns 617 shares of the healthcare conglomerate’s stock valued at $325,000 after buying an additional 52 shares in the last quarter. Echo45 Advisors LLC grew its stake in shares of UnitedHealth Group by 3.0% in the fourth quarter. Echo45 Advisors LLC now owns 885 shares of the healthcare conglomerate’s stock valued at $466,000 after buying an additional 26 shares in the last quarter. Fidelis Capital Partners LLC grew its stake in shares of UnitedHealth Group by 30.3% in the fourth quarter. Fidelis Capital Partners LLC now owns 7,169 shares of the healthcare conglomerate’s stock valued at $3,774,000 after buying an additional 1,669 shares in the last quarter. Xponance Inc. grew its stake in shares of UnitedHealth Group by 4.2% in the fourth quarter. Xponance Inc. now owns 201,906 shares of the healthcare conglomerate’s stock valued at $106,297,000 after buying an additional 8,226 shares in the last quarter. Finally, Guardian Investment Management acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $1,911,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have commented on UNH. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Trading Up 1.8 %

Shares of UNH stock traded up $9.01 during trading hours on Friday, hitting $502.19. 2,029,402 shares of the company were exchanged, compared to its average volume of 4,491,010. The firm has a market cap of $462.98 billion, a P/E ratio of 30.69, a P/E/G ratio of 1.31 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The company has a 50 day simple moving average of $488.97 and a two-hundred day simple moving average of $515.22.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the firm posted $6.26 EPS. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.